Windlas Biotech Stock Forecast

Buy candidate since Jun 12, 2026

The Windlas Biotech Limited stock price gained 1.60% on the last trading day (Friday, 12th Jun 2026), rising from ₹811.30 to ₹824.30. During the last trading day the stock fluctuated 2.95% from a day low at ₹806.20 to a day high of ₹830.00. The price has been going up and down for this period, and there has been a -1.06% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 19 thousand more shares were traded than the day before. In total, 66 thousand shares were bought and sold for approximately ₹54.30 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.64% during the next 3 months and, with a 90% probability hold a price between ₹834.06 and ₹989.56 at the end of this 3-month period.

WINDLAS.NS Signals & Forecast

Mostly positive signals in the chart today. The Windlas Biotech Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at ₹818.61 and ₹820.62. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 13, 2026, and so far it has risen 8.19%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Windlas Biotech Limited stock

Windlas Biotech Limited finds support from accumulated volume at ₹789.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹23.80 between high and low, or 2.95%. For the last week, the stock has had daily average volatility of 3.29%.

Our recommended stop-loss: ₹777.15 (-5.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (WINDLAS.NS) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Windlas Biotech Limited to open at ₹820.17, and during the day (based on 14 day Average True Range), to move between ₹809.36 and ₹839.24, which gives a possible trading interval of +/-₹29.88 (+/-3.69%) up or down from last closing price. If Windlas Biotech Limited takes out the full calculated possible swing range there will be an estimated 3.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at ₹833.10 (1.07%) than the support at ₹789.95 (4.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Windlas Biotech Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Windlas Biotech Limited stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.043 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - ₹820.17 ( 0.501%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk